Navigation Links
Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
Date:8/6/2012

SAN MATEO, Calif., Aug. 6, 2012 /PRNewswire/ -- Nile Therapeutics, Inc. (OTCQB: NLTX), a biopharmaceutical company that develops novel therapeutics for heart failure patients, today announced that it has promoted Darlene Horton, M.D. to President and Chief Executive Officer, and appointed her as a director of the Company.

(Photo: http://photos.prnewswire.com/prnh/20120806/SF52295)

"We are pleased Dr. Horton has agreed to assume the role of Chief Executive Officer," said Richard Brewer, Chairman of the Board of Directors of Nile. "We believe Dr. Horton's knowledge and experience in the heart failure space will help Nile to realize the full value of the cenderitide post-acute program."

"I am excited to assume the leadership role at Nile," said Darlene Horton, M.D., Chief Executive Officer of Nile. "I am particularly compelled by cenderitide's potential to fundamentally change how we treat heart failure patients following an acute event. I believe the dual receptor activating properties of cenderitide, combined with proven out-patient, subcutaneous delivery technology, provides a unique opportunity to potentially reduce re-hospitalizations and improve the quality of life for these patients."

Dr. Horton served as Nile's Chief Medical Officer from June 2012 until her appointment as its CEO.  Previously, she served as Chief Medical Officer of Itero Biopharmaceuticals, a venture-backed biosimilar company.  As a co-founder of Itero, she helped raise $17 million in capital and lead the development team. The product was successfully out-licensed to Watson Pharmaceuticals. Previous to Itero, Dr. Horton served as Senior Vice President, Clinical Research at Scios, Inc., a Johnson & Johnson (J&J) company. During her 12 year tenure at Scios, she was the clinical lead for Natrecor®, a commercial product indicated for the treatment of acute heart f
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2. Silence Therapeutics - Admission of Shares and Board Update
3. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
4. OrPro Therapeutics Receives NIH Grant Award to Advance Development of Recombinant Thioredoxin for Treatment of Cystic Fibrosis
5. Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
6. ADVENTRX Pharmaceuticals to Present at 1st Annual Sickle Cell Disease Therapeutics Conference
7. Karyopharm Therapeutics Initiates Two Phase 1 Trials with Oral KPT-330, the First Selective Inhibitor of Nuclear Export (SINE), in Patients with Advanced Cancers
8. Actinium Pharmaceuticals Inc. Pays Regulatory Milestone to Abbott Biotherapeutics Corp.
9. PTC Therapeutics Closes $30 Million Financing
10. Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
11. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015 Research ... addition of the "Endoscopy Global Market - ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,The ... $43 billion by 2019 growing at around 7.0% ... for the market growth are aging population, increase ...
(Date:4/27/2015)... 27, 2015 Vermillion, Inc. (VRML), ... disease, announced today it will report first ... close on Monday, May 11, 2015, followed ... at 4:30pm Eastern.Conference Call & Webcast: Monday, ... Domestic: , 888-556-4997International: , 719-457-2628Conference ID: , ...
(Date:4/27/2015)... 2015  Agena Bioscience today announced Bioyong Technology as the ... in China . "The Chinese ... hotbed for practical, meaningful innovations that are improving human health ... rest of the world. We are proud to support the ... ," said Peter Dansky , Agena Bioscience,s CEO. ...
Breaking Medicine Technology:Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 2Endoscopy Global Market - Forecast to 2020: Market is expected to reach approximately $43 billion with Johnson and Johnson, Olympus and Covidien Dominating 3Agena Bioscience Names Bioyong Technology as Fifth Certified Service Provider in China 2
...  BioInformatics, LLC announces the pending release of three Q4 ... & Brand Assessment (#10-006) Exploring Structural Biology:  Tools ... Structure (#10-004) Genomic Technologies:  Market Insights for Life ... who provide product and services to these three rapidly ...
... Oct. 14 Octapharma USA ... Grants Program , which supports clinical or pre-clinical research ... therapy, intensive care and emergency medicine. The application deadline ... , one of the largest human protein products manufacturers ...
Cached Medicine Technology:BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 2BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 3BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure 4Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies 2
(Date:4/27/2015)... As ISO 27001 has quickly become the de ... sizes and in all industries, Pivot Point Security has ... 27001 certification. The information security audit firm has worked ... 27001 certification. Pivot Point's commitment to ISO 27001 is ... Lead Implementers and Auditors the company employs (now ten ...
(Date:4/27/2015)... Data Integrity Problems on the Rise: , ... Partners/Suppliers, **FDAnews Webinar**, May 19, 2015 — 1:30 p.m. ... integrity issues have become a common and ever increasing ... issues within manufacturing operations or partner networks can be ... remediating them can be even more difficult. , ...
(Date:4/27/2015)... 27, 2015 Cannabix Technologies Inc. (CSE: ... Mr. Rocco Iannapollo has become an Advisor to Cannabix ... law enforcement and workplace testing. Mr. Iannapollo is an ... years of experience in the oil and gas industry, ... with supplier, employer, and DOT compliance policies and strategies. ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 The ... at a lower CAGR in developed countries; however, ... emerging countries such as China, India and Brazil ... coagulation analyzers market is driven by factors such ... diagnostics laboratories, development of high-throughput hemostasis analyzers, developments ...
(Date:4/27/2015)... April 27, 2015 The Global Pharmaceutical ... at a CAGR of 5.9% during the period 2015 ... in the materials healthcare packaging market, mainly due to ... Pharmaceutical Packaging market is extremely fragmented with the ... major portion of the market with the rest being ...
Breaking Medicine News(10 mins):Health News:Six Additional New ISO 27001 Lead Implementers Certified for Pivot Point Security 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4
... (May 8, 2011) Research being presented at ... diet affects gastrointestinal illnesses, such as gallstones and ... their digestive problems are caused by lactose intolerance ... DDW is the largest international gathering of physicians ...
... drug often prescribed for women with Crohn,s disease, actively ... and remains in a newborn,s bloodstream for at least ... Francisco have found. The new study has ... because ADA is known to decrease the immune system,s ...
... FRIDAY, May 6 (HealthDay News) -- Mutations in a single ... of the human cerebral cortex, the part of the brain ... language, memory, attention and consciousness. That,s the finding of ... three families -- one Turkish, two Pakistani -- with children ...
... -- Fathers have a major influence on how often their ... research shows. The study included 312 families in Houston ... about family meals and the amount of time the children ... families were aged 9 to 11 and 13 to 15. ...
... Reporter , THURSDAY, May 5 (HealthDay News) -- ... appendicitis, surgery remains the more effective treatment, French ... with antibiotics alone, but complicated appendicitis, where the ... difficult to discern between the two, the researchers ...
... Dr. Rino Rappuoli has been chosen to receive the 2011 ... by the European Society of Clinical Microbiology and Infectious Diseases ... his outstanding contributions in the field of vaccines and vaccinology. ... researcher at the 21st ECCMID / 27th ICC meeting in ...
Cached Medicine News:Health News:Dietary research offers new explanations and treatments approaches for gastrointestinal disorders 2Health News:Dads Who Eat Out Have Kids Who Eat Out, Study Finds 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 2Health News:Surgery May Beat Antibiotics for Appendicitis, Study Finds 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: